Clin Infect Dis. 2025 Sep 9:ciaf354. doi: 10.1093/cid/ciaf354. Online ahead of print.
ABSTRACT
This article provides a focused update to the clinical practice guideline on the treatment and management of patients with coronavirus disease 2019 (COVID-19), developed by the Infectious Diseases Society of America. The guideline panel presents a recommendation on the use of abatacept in hospitalized adults with severe or critical COVID-19. The recommendation is based on evidence derived from a systematic literature review and adheres to a standardized methodology for rating the certainty of evidence and strength of recommendation according to the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) approach.
PMID:40923137 | DOI:10.1093/cid/ciaf354
